Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, SP, Brazil.
Curr Neurol Neurosci Rep. 2012 Feb;12(1):10-6. doi: 10.1007/s11910-011-0235-6.
Stroke is the fourth leading killer in the United States and a leading cause of adult long-term disability. The American Heart Association estimates that only 3% to 5% of patients with acute ischemic stroke are treated with intravenous thrombolysis. A way to improve the rates of treatment with thrombolysis in patients with acute ischemic stroke is the creation of telemedicine stroke networks. Data from many studies support the safety of expanding intravenous tissue plasminogen activator use with the help of telemedicine. In this article we discuss the current evidence for the use of telemedicine within stroke systems of care, the importance of coordinating care within the transferring facilities in the telestroke networks, telestroke economics and applicability, and how to potentially use the telestroke systems to increase recruitment of patients into acute stroke thrombolysis trials.
中风是美国的第四大致死原因，也是成年人长期残疾的主要原因。美国心脏协会估计，只有 3%至 5%的急性缺血性中风患者接受了静脉溶栓治疗。提高急性缺血性中风患者溶栓治疗率的一种方法是建立远程医疗中风网络。许多研究的数据支持在远程医疗的帮助下扩大静脉组织型纤溶酶原激活剂使用的安全性。在本文中，我们讨论了远程医疗在中风护理系统中的应用的现有证据，讨论了在远程中风网络中转诊机构中协调护理的重要性，讨论了远程中风的经济学和适用性，以及如何利用远程中风系统来增加急性中风溶栓试验的患者招募。
